Evidence map›Paper›PMID 32180242›Full record

ReviewElectrophoresis2020

Liquid biopsy technologies based on membrane microfluidics: High-yield purification and selective quantification of biomarkers in nanocarriers.

Ceming Wang, Satyajyoti Senapati, Hsueh-Chia Chang

Open access · greenAbstract readReview
In one paragraph

Review in Electrophoresis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Multi-Modal Microfluidics (MMicromachines · 2022
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ceming WangDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
Satyajyoti SenapatiDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.ORCID 0000-0001-7999-1561
Hsueh-Chia ChangDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
University of Notre Dame · US

Funding

High-Throughput Electrokinetic Fractionation and Analysis of Extracellular RNA Nano-CarriersUG3CA241684 · NCI · UNIVERSITY OF NOTRE DAME · PI CHANG, HSUEH-CHIA · 2019 to 2020
$927k
A Solid-State Nanopore miRNA Quantification TechnologyR21CA206904 · NCI · UNIVERSITY OF NOTRE DAME · PI CHANG, HSUEH-CHIA, SENAPATI, SATYAJYOTI · 2016 to 2018
$618k
An Integrated Microfluidics Platform for Rapid and Sensitive Exosome RNAR21HG009010 · NHGRI · UNIVERSITY OF NOTRE DAME · PI CHANG, HSUEH-CHIA, GO, DAVID B. · 2016 to 2017
$421k
Develop a Multi-Target Sensor to Detect Dengue Serotypes from Infected MosquitoesR21AI105361 · NIAID · UNIVERSITY OF NOTRE DAME · PI SENAPATI, SATYAJYOTI · 2014 to 2015
$418k
National Science Foundation NSF-CBET 1065652NCI NIH HHS R21 CA206904NCI NIH HHS UG3 CA241684NHGRI NIH HHS R21 HG009010NIAID NIH HHS R21 AI105361U.S. Department of Agriculture 2012‐67005‐19589
6 · The paper itself

Abstract

Liquid biopsy, screening cancer non-invasively and frequently by detecting and quantifying molecular markers in physiological fluids, would significantly improve cancer survival rate but it remains a distant goal. The key obstacles presented by the highly heterogeneous samples are rapid/high-yield purification and precise/selective marker capture by their antibody and oligo probes. As irregular expressions of these molecular biomarkers are the key signals, quantifying only those from the cancer cells would greatly enhance the performance of the screening tests. The recent discovery that the biomarkers are carried by nanocarriers, such as exosomes, with cell-specific membrane proteins suggests that such selection may be possible, although a new suite of fractionation and quantification technologies would need to be developed. Although under-appreciated, membrane microfluidics has made considerable contributions to resolving these issues. We review the progress made so far, based on ion-selective, track-etched, and gel membranes and advanced electrophoretic and nano-filtration designs, in this perspective and suggest future directions.

Indexed as

Biomarkers, TumorEarly Detection of CancerExtracellular VesiclesHigh-Throughput Screening AssaysHumansLiquid BiopsyMicrofluidic Analytical TechniquesNanoporesBiomarkers, TumorCancerExtracellular vesiclesHigh-throughputLiquid biopsyNanopore

Identifiers

PMID32180242
PMCPMC7492446
OpenAlexW3011695262

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.